613 results about "Osteo arthritis" patented technology

The invention relates to the technical field of medical data processing, in particular to a knee osteoarthritis acupuncture curative effect prediction system based on deep learning. The system obtains acupuncture treatment parameters and acupuncture effect parameters of historical knee osteoarthritis patients; the historical knee osteoarthritis patients are divided into patient categories based on the acupuncture effect parameters, and the contribution degree is obtained according to the distribution of each acupuncture treatment parameter in each patient category and the distribution difference between the acupuncture treatment parameter and the acupuncture treatment parameter in other patient categories; acquiring a local curative effect feedback value according to the contribution degree and the acupuncture effect parameter, and further acquiring an evaluation score; and training the acupuncture curative effect prediction model through the acupuncture treatment parameters, the evaluation scores and the acupuncture effect parameters to obtain a trained acupuncture curative effect prediction model. According to the method, the evaluation score is dynamically obtained, the participation degree of each acupuncture treatment parameter of each historical knee osteoarthritis patient is accurately determined, and the accuracy of acupuncture treatment effect prediction model training is effectively improved.

The invention belongs to the technical field of biological medicines, and discloses a DSH loaded medicine as well as a preparation method and application thereof. The DSH loading type medicine is DNA (Deoxyribonucleic Acid) supramolecular hydrogel loaded with 2, 2, 6, 6-tetramethylpiperidine-1-oxide, and the DSH loading type medicine is a DNA supramolecular hydrogel loaded with the 2, 2, 6, 6- Wherein the DNA supramolecular hydrogel is formed by assembling a Y type DNA monomer and an L type DNA monomer. The DSH loaded medicine has good anti-inflammatory and peroxy free radical removing effects, and can achieve the purpose of treating knee osteoarthritis. In addition, the DSH loaded medicine can be used for reflecting the content of peroxy free radicals in knee joints by detecting the contrast ratio of knee joint images through magnetic resonance, and early diagnosis of knee osteoarthritis is achieved.

The invention belongs to the technical field of biomedical anti-inflammatory gels, and discloses a renewable boundary lubrication natural polyphenol anti-inflammatory hydrogel and a preparation method and application thereof.The hydrogel is of a hydrophilic viscoelastic sea island structure, gallic acid grafted gelatin blended with hyaluronic acid serves as a base material, celecoxib lipidosome is entrapped in the hydrogel, and the hydrogel is prepared from natural polyphenols, an articular cavity is injected through an enzyme crosslinking technology to form gel, hyaluronic acid and lipidosome form a hydrated lubricating layer on a cartilage-gel interface, and after the interface is abraded, internal lipidosome and hyaluronic acid are exposed to supplement lubrication so as to form sustainable lubrication; the liposome responds to friction shear crushing to release celecoxib and cooperates with gallic acid at an interface to resist inflammation progress and repair cartilage, the injectable hydrogel is developed based on gallic acid, hyaluronic acid, gelatin and celecoxib liposome to treat early osteoarthritis, mechanical lubrication and inflammation resistance are combined, and the preparation method has the advantages that the preparation method is simple, the preparation cost is low, and the application prospect is wide. The problems of large-dose toxicity, short lubrication period and the like caused by independent treatment are effectively solved, and the preparation has important clinical application significance.

The invention relates to the technical field of preparation of astaxanthin sustained-release microspheres, and discloses chitosan-based astaxanthin sustained-release microspheres and a preparation method thereof.The method comprises the steps that chitosan powder is dissolved in an acetic acid solution, the pH value is adjusted, and a chitosan solution is prepared; dissolving astaxanthin in ethanol, and then adding the chitosan solution; adding a cross-linking solution into the emulsified solution, and performing cross-linking under a magnetic stirring condition to form astaxanthin sustained-release microspheres; adding the astaxanthin sustained-release microspheres into a strengthening solution for strengthening treatment; carrying out coating treatment on the astaxanthin sustained release microspheres subjected to the strengthening treatment; carrying out centrifugal treatment on the solution subjected to coating treatment, and collecting astaxanthin sustained-release microspheres subjected to centrifugal separation; and washing the collected astaxanthin sustained-release microspheres with PBS (Phosphate Buffer Solution). According to the invention, chitosan is used as a carrier to prepare the astaxanthin sustained-release microspheres, so that the astaxanthin can be continuously and stably released in intestinal tracts, the antioxidant and anti-inflammatory activity of the astaxanthin can be fully exerted, and further, the astaxanthin sustained-release microspheres have an effective treatment effect on osteoarthritis.

The invention relates to the field of disease animal model construction, and particularly discloses a postmenopausal osteoporosis and knee osteoarthritis co-disease animal model construction method which comprises the following steps: selecting a female animal as an experimental subject; the selected female animals are injected with a GnRH agonist, meanwhile, low-calcium feed feeding and oxidative stress stimulation are conducted, and feeding is conducted for a preset time; detecting bone mineral density and bone trabecula parameters of the fed female animals, and screening qualified female animals meeting set standards; performing meniscus tearing operation on the qualified female animal, and implanting sustained release microspheres loaded with inflammatory factors at the torn part during the operation; carrying out weight-bearing training on the female animal after the operation, and continuing for a set time length; and performing health detection on the female animals at different time points. According to the method, through multi-factor collaborative induction of the PMOP, minimally invasive construction of the KOA and multi-dimensional health detection, accurate simulation of a co-disease pathological process and clinical characteristics is realized, and the authenticity and stability of the model are improved.

The invention relates to the technical field of biological medicines, in particular to an umbilical cord source mesenchymal stem cell exosome preparation, a preparation method and application in preparation of osteoarthritis medicines. The preparation is prepared by the method. The method comprises the following steps: pretreating umbilical cord-derived mesenchymal stem cells by adopting a pretreating agent; removing the pretreatment agent, and carrying out gradient centrifugation treatment on the pretreated umbilical cord source mesenchymal stem cells to obtain exosome precipitate; and re-suspending the exosome precipitate in a buffer solution containing a protease inhibitor to obtain the umbilical cord source mesenchymal stem cell exosome preparation. The application refers to the application of the preparation in preparation of osteoarthritis drugs. The problems of low yield and functional heterogeneity of EXO obtained by a conventional culture method are solved.

The invention provides a nanogel for rapid permeation of articular cartilage and responsive release of a growth factor, which is prepared by polymerizing a peptide fragment which can be cut by a substance (mainly enzyme) which can be specifically expressed on the surface of osteoarthritis cells or secreted into a matrix with the growth factor, an acrylamide monomer and a cationic micromolecule monomer. Unreacted monomer molecules are filtered out through an ultrafiltration tube or other filtering systems, so that the nanogel which can rapidly permeate into the deep part of articular cartilage and can be recognized and cut by enzyme highly expressed on the surface of osteoarthritis cells or secreted enzyme to release growth factors is prepared, and the effect of the growth factors can be more effectively exerted; the nanogel has strong cartilage infiltration capacity, can completely infiltrate cartilage with the thickness of 1mm within less than 3 days, can be cut by MT1-MMP protein specifically expressed on the surfaces of osteoarthritis cells, releases growth factors, is specifically combined with growth factor receptors on the surfaces of cartilage cells, and activates downstream signal channels, so that the proliferation of the cartilage cells is promoted, and the cartilage cell proliferation rate is increased. The cartilage matrix secretion is promoted, so that the cartilage matrix thickening effect is realized, and the osteoarthritis is prevented and treated.

The invention discloses HA-PAS hydrogel for enhancing cartilage repair of early osteoarthritis and a preparation method of the HA-PAS hydrogel. According to the hydrogel, formylated hyaluronic acid, hydrazide modified low-methoxyl pectin and phenylboronic acid modified alginate form a ternary polysaccharide skeleton, a double-dynamic cross-linked network is formed through acylhydrazone bonds and boric acid ester bonds, and a triple network structure is formed by combining permanent cross-linking catalyzed by horse radish peroxidase. The hydrogel integrates functional components such as nano-selenium, a pulullan-strontium chelate and a mesenchymal stem cell source exosome, so that multiple effects of resisting oxidation, resisting inflammation, promoting cartilage differentiation and repairing subchondral bones are achieved. The compression modulus of the hydrogel is 0.8-1.5 MPa, and the hydrogel can be injected for in-situ gelling and MMP responsive degradation, shows an excellent cartilage repair effect in animal experiments, and provides a new solution for treatment of early osteoarthritis.

The invention relates to the technical field of biological medicines, and discloses a polypeptide for treating osteoarthritis by aiming at AHR (Aryl Hydrocarbon Receptor), the amino acid sequence of the polypeptide is GFQQSDVIHQSVYELISINHTEDRA, and the amino acid sequence of the polypeptide is GFQQSDVIHQSVYELISINHTEDRA, and the amino acid sequence of the polypeptide is GFQQSDVIHQSVYELISINHTEDRA. The polypeptide is prepared by a solid-phase polypeptide synthesis method; the solid-phase polypeptide synthesis method specifically comprises the following steps: synthesizing from a C end to an N end, connecting a carboxyl group of a first amino acid to insoluble resin, then adding other amino acids one by one to form a peptide chain, and carrying out protection and deprotection reactions of a side chain in each step. The polypeptide is composed of natural amino acids and has good biocompatibility and degradability, and experimental results show that no obvious toxic reaction occurs in the cell level and the animal level, so that the polypeptide has conditions for further development of pharmacokinetic research and preclinical tests, and a feasible basis is provided for conversion to clinical application.

The invention belongs to the technical field of food and medicine, and relates to application of corn germ concentrated powder in improvement of osteoarthritis. The invention particularly relates to application of corn germ concentrated powder, namely corn antioxidant multienzyme, in preparation of medicines or health-care foods for treating rheumatoid arthritis and osteoporosis. In the corn germ concentrated powder, superoxide dismutase / (U / g) is greater than or equal to 8500, glutathione peroxidase / (U / g) is greater than or equal to 5000, and catalase / (U / g) is greater than or equal to 750. The corn germ concentrated powder can also be prepared by the following method: cleaning corn, germinating, adding water into the germinated corn, grinding and pulping, adding a settling agent into the corn steep liquor, standing, taking supernate, adding part of sodium ascorbate, performing temperature-controlled concentration, adding the rest sodium ascorbate and a stabilizer into the concentrated solution, and uniformly mixing to obtain the corn germ concentrated powder. And drying at controlled temperature, crushing, and mixing with a proper amount of silicon dioxide. The prepared corn germ concentrated powder has the effect of resisting rheumatoid arthritis.

The application provides an improved hyaluronic acid injection preparation for inflammation targeting and stem cell capture, a preparation method and use thereof, and belongs to the field of medicine. The injection preparation is prepared from unsaturated bond modified hyaluronic acid, stem cell targeting DNA tetrahedron and thiol modified inflammation targeting aptamer as raw materials. The injection preparation can be targeted to accumulate at an osteoarthritis site, capture mesenchymal stem cells in situ, recruit mesenchymal stem cells to the osteoarthritis site, promote differentiation of stem cells into cartilage, promote cartilage repair, play a role in treating osteoarthritis, and has a good application prospect.

The invention discloses a knee osteoarthritis dynamic grading prediction and intervention system and method based on a large model, and relates to the field of medical image analysis, and the method comprises the steps: obtaining a knee joint MRI image sequence and knee joint angle time sequence data of a patient; processing the MRI image sequence by using a pre-trained articular cavity segmentation model to obtain a joint fluid volume quantized value; aligning the knee joint angle time sequence to an image frame acquisition time point to generate a synchronous angle sequence; whether the average value of the liquid amount change rate sequence is lower than a preset stable threshold value or not is judged by calculating the liquid amount change rate sequence and the angle change quantity sequence, and if yes, a low-risk signal is output; otherwise, calculating a correlation coefficient between the liquid amount change rate and the angle change amount, outputting a moderate or severe gonitis prediction signal according to the value of the correlation coefficient, and further judging the mild or moderate risk of the gonitis according to the amplitude characteristics of the liquid amount change rate sequence; according to the invention, early gonitis lesion features can be identified, and the accuracy of grading prediction is improved.

Disclosed herein are methods of treatment of pain associated with osteoarthritis, pain associated with osteonecrosis, and pain associated with one or more subchondral insufficiency fractures; methods of improving physical function in a human subject with osteoarthritis, osteonecrosis, or one or more subchondral insufficiency fractures; and methods of treating osteoarthritis, or delaying or slowing the progression of osteoarthritis, or relieving a symptom of osteoarthritis, in humans with these diseases, comprising administering a therapeutically effective amount of a composition comprising a glycosylated p75NTR neurotrophin binding protein (NBP)-Fc fusion protein.

Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures. Also described herein are methods and compositions for using probiotics and prebiotics for management of inflammation, and symptoms of menopause.

The invention belongs to the technical field of bioengineering and application thereof, and particularly relates to a laver compound zymolyte as well as a preparation method and application thereof. The compound enzyme is prepared through a compound enzymolysis process of protease and laver polysaccharide enzyme. Compared with a traditional single proteolysis process, a composite enzymolysis process of adding the high-enzyme-activity laver polysaccharide enzyme effectively breaks a'polysaccharide-protein 'composite structure of laver cell walls, so that the viscosity of zymolyte is reduced, high laver liquefaction rate and high product yield are realized, and the release efficiency of nutritional active ingredients is remarkably improved; the product is rich in low-molecular-weight polypeptide and oligomeric porphyra polysaccharide. The obtained zymolyte shows the comprehensive effects of improving joint activity, inhibiting osteophyte formation, adjusting cartilage metabolism balance and relieving inflammatory response in an osteoarthritis mouse model, and osteoarthritis is effectively relieved. According to the invention, efficient release and utilization of nutritional active ingredients of the laver are realized, and powerful technical support is provided for developing high-valued products, such as health-care products and functional foods, which have the function of maintaining joint health.

The invention discloses a specific disease iconography feature extraction method and system based on deep learning, and relates to the technical field of image analysis, and the method comprises the steps: collecting X-ray image data, stem cell markers, magnetic resonance imaging image data and dynamic ultrasonic image data of an osteoarthritis patient; performing standardization processing on the X-ray image data, the stem cell marker, the magnetic resonance imaging image data and the dynamic ultrasonic image data to obtain a standardized X-ray image data set, a standardized stem cell marker, a standardized magnetic resonance imaging image data set and a standardized dynamic ultrasonic image data set; a standardized X-ray image data set, a standardized magnetic resonance imaging image data set and a standardized dynamic ultrasound image data set are acquired. According to the invention, through multi-modal image data fusion and biomechanics-stem cell characteristic dynamic coupling, early accurate diagnosis and repair potential evaluation of osteoarthritis are realized.

The present disclosure describes devices, methods and systems for modifying or altering gait kinematics via sensory augmentation and / or modifying muscle activation patterns via augmented motor learning to slow the progression of and / or reduce the pain associated with knee OA, particularly during gait (e.g., walking, running, stair climbing, etc.). Sensors can be used to measure gait parameters and characteristics and muscle activation patterns. Stimulation can be provided to the individual in order to promote learning new gait kinematics and muscle activation patterns.

The invention provides application of apoptotic cell pretreated macrophages in preparation of an osteoarthritis treatment preparation, a cell preparation and a preparation method, and relates to the technical field of biomedicine.In the embodiment of the invention, based on a mouse development model and an osteoarthritis (OA) model, it is found that in the area away from the cartilage surface, the apoptotic cell pretreated macrophages are subjected to apoptotic cell pretreatment, and the apoptotic cell pretreated macrophages are subjected to apoptotic cell pretreatment in the area away from the cartilage surface; in the macrophages, the content of the interment-related LAMP1 protein is obviously higher than that of the macrophages close to the cartilage surface area, and the expression results of TGF-beta 1 and LRG1 are respectively opposite and consistent with those of the LAMP1. The invention also finds that after the chemotactic effect of apoptotic cells on macrophages is weakened, the cellular burial effect is limited, and the cartilage matrix development disorder is caused. Based on development process inspiration, the invention provides a treatment strategy: bone marrow-derived macrophages pretreated by apoptotic cells are injected into articular cavities, and a good cartilage regeneration treatment effect can be achieved in a mouse arthritis model. In addition, the bone marrow-derived macrophages pretreated by apoptotic cells can still express TGF-beta1 after being injected into the body for 3 days, so that the effect of continuously promoting cartilage regeneration is achieved.

Provided herein are quinazolinone compounds for modulating muscle myosin to treat obesity and related disorders such as cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, cancer, and osteoarthritis.

The invention relates to application of a miR-155-5p inhibitor delivered by an exosome of a targeted synovitis macrophage to treatment of osteoarthritis, and belongs to the technical field of biological medicines. According to the scheme, the exosome drug delivery system for targeting the synovial inflammatory macrophages in the osteoarthritis, which contains the miR-155-5p inhibitor, is prepared through a genetic engineering technology, so that the exosome derived from stem cells is targeted to inflammatory synovial tissues, and damaged cartilage tissues are repaired and inflammation is resisted based on the stem cell exosome; compared with the prior art, the application has the advantages that the combined action of inhibiting the osteoarthritis injury and inhibiting the miR-155-5p so as to resist synovitis is realized, the osteoarthritis injury repair can be better applicable, a new scheme for treating the osteoarthritis is provided, a support is provided for clinical transformation, and the application value is extremely high.

Various embodiments are provided relating to caninized, feline, or equine antibodies that bind canine, feline, and / or equine IL23 and / or TNFα, including bispecific antibodies that bind both IL23 and TNFα. Such antibodies may be used alone or in combination in methods for treating canine, feline, and / or equine subjects with inflammatory conditions, such as inflammatory bowel disease (IBD), osteoarthritis, and inflammatory conditions such as gastroenteritis in dogs and cats.

The invention belongs to the technical field of osteoarthritis management, and particularly relates to an osteoarthritis management system based on artificial intelligence and a computer storage medium. The invention provides an osteoarthritis management system based on artificial intelligence. The system integrates an LLM-DL hybrid architecture, a multi-specialist module cooperation framework and an RAG knowledge base system, and can cover a complete clinical process from patient preliminary diagnosis to treatment scheme formulation. The system can comprehensively and accurately evaluate the disease state of a patient, provides personalized disease progress prediction, not only predicts 2-year and 4-year functional results and iconography progress, but also can identify specific risk factors of the patient, and provides a basis for accurate intervention. Through the design of the whole system, the clinical working efficiency and the prediction accuracy are remarkably improved, the dependence on specialist doctors and high-end equipment is reduced, high-quality KOA management can also be implemented in resource limited areas, and therefore the overall medical resource requirement is effectively reduced.

The present invention relates to a composition comprising 4-hexylresorcinol (4-HR) as an active ingredient for prevention or treatment of a bone disease, and a formulation thereof. The composition comprising 4-hexylresorcinol (4-HR) as an active ingredient, or an ointment thereof was found to improve bone thickness, density, and strength and control bone remodeling by promoting the differentiation of osteoblasts and suppressing the proliferation and differentiation of osteoclasts in osteoporosis-induced animal models. Thus, the composition or ointment comprising 4-hexylresorcinol (4-HR) as an active ingredient can be provided as a therapeutic agent for bone diseases including bone fracture, osteoarthritis, rheumatoid arthritis, and osteoporosis.

The invention discloses a resource adaptive federated learning-based multi-modal knee osteoarthritis auxiliary diagnosis method, which comprises the following steps that: a server initializes a knee osteoarthritis diagnosis-oriented multi-modal model, and pre-deploys a low-rank adaptive plug-in in a trainable layer; after the client reports local hardware resources, the server allocates a resource echelon and issues a two-dimensional cutting proportion; the client performs depth and width cutting on the model based on the cutting proportion, activates a LoRA module of a specified layer, loads local knee joint X-ray images and clinical text data to perform multi-modal training, and establishes semantic mapping of image features and clinical description; the client only uploads and activates the LoRA parameter update quantity, and the server optimizes the global model through weighted average aggregation and key layer compensation; and in combination with real-time resource monitoring and knowledge distillation, the learning ability of the model for key discriminant features of knee osteoarthritis is enhanced. According to the method, heterogeneous computing power equipment is covered through a resource adaptive mechanism, and the participation efficiency of basic medical institutions is improved.

To provide a compound and the use thereof for the treatment for regeneration of connective tissue following the degeneration process of articular cartilage due to osteoarthritis, in the case of humans, the degeneration process of articular cartilage caused by excessive stress, for the treatment of skin aging, and for the prevention of skin cancer.SOLUTION: For example, an amino acid derivative of glucosamine having the following structure is provided.SELECTED DRAWING: None

The present disclosure provides methods and compositions comprising hyaluronic acid (HA) hydrogel in combination with a saturated fatty acid for treating osteoarthritis. In some embodiments, aspects of the disclosure relate to pharmaceutical compositions comprising HA hydrogel in combination with a steroid. In some embodiments, the pharmaceutical compositions may be administrable via local, topical, and injection. In some embodiments, the pharmaceutical composition may be administrable by intra-articular injection.

The present disclosure is generally directed to treating a subject having osteoarthritis or confronting risk of developing osteoarthritis by administering an inhibitor of cartilage interlayer protein 2 (CILP2) to the subject.

This invention belongs to the field of pharmaceutical technology, specifically relating to the application of oleanolic acid in promoting chondrogenic differentiation of chondrocytes. This invention discovers that oleanolic acid promotes the expression of proteoglycans and calcium deposition in ATDC5 cells undergoing chondrogenic differentiation, and also promotes the expression of ATDC5 cell chondrogenic differentiation markers. Therefore, it has the potential to be formulated into a drug that can promote chondrogenic differentiation of chondrocytes, thereby promoting cartilage repair and regeneration for the treatment of osteoarthritis and rheumatoid arthritis.

The invention discloses an organic framework microgel for relieving osteoarthritis and application thereof.The organic framework microgel takes a cross-linked HAMA hydrogel network as a matrix and a skeleton of the whole microgel, and HAMA inherits and strengthens inherent excellent lubricating performance and biocompatibility of hyaluronic acid; according to the present invention, the HAMA matrix and the TA-ZIF-8 nano-particles are uniformly dispersed in the lubrication matrix so as to directly and enduringly improve the lubrication state of the joint, and the TA-ZIF-8 nano-particles are adopted as the treatment unit to be uniformly dispersed in the lubrication matrix, such that the matrix-wrapping structure ensures that the lubrication function (provided by the HAMA matrix) and the treatment function (provided by the TA-ZIF-8) can synchronously and continuously act in the whole period of the microgel retention in the joint cavity.

This invention relates to a multifunctional rehabilitation robot for knee osteoarthritis based on a rope-driven four-bar linkage structure, comprising a shell, a main control drive module, a knee joint wearable module, a knee joint connection and transmission module, and a detachable load-free module. The main control drive module is housed within the backpack shell. The knee joint wearable module includes a femoral wearable unit and a tibial wearable unit, connected via the knee joint connection and transmission module. The knee joint connection and transmission module includes a four-bar linkage structure and a rope drive assembly, which drives the four-bar linkage structure to achieve knee flexion and extension. The detachable load-free module includes a hip support unit and a leg support unit; the hip support unit is connected to the femoral wearable unit, and the leg support unit is connected to the tibial wearable unit. Compared with existing technologies, this invention effectively addresses the rehabilitation needs of patients with knee osteoarthritis and helps patients with varying degrees of varus / valgus aberration correction achieve assisted walking, load-free operation, rehabilitation training, and varus / valgus correction.